Chronic obstructive pulmonary disease outcome measurements: what's important? What's useful?
about
Long-term oxygen therapy for patients with chronic obstructive pulmonary disease (COPD): an evidence-based analysisImpact of self-reported gastroesophageal reflux disease in subjects from COPDGene cohort.Lung volume reduction surgery and pulmonary rehabilitation improve exercise capacity and reduce dyspnea during functional activities in people with emphysema.Chronic obstructive pulmonary disease in older persons: A comparison of two spirometric definitionsRelationships between repeated instruction on inhalation therapy, medication adherence, and health status in chronic obstructive pulmonary disease.Level of daily physical activity in individuals with COPD compared with healthy controls.The ratio of FEV1 to FVC as a basis for establishing chronic obstructive pulmonary diseaseThe chronic bronchitic phenotype of COPD: an analysis of the COPDGene StudyRespiratory impairment and mortality in older persons: a novel spirometric approach.Pulmonary rehabilitation: An overview.Staging the severity of chronic obstructive pulmonary disease in older persons based on spirometric Z-scores.Is generalization of exhaled CO assessment in primary care helpful for early diagnosis of COPD?Distance saturation product predicts health-related quality of life among sarcoidosis patients.Spirometric correlates of dyspnea improvement among emergency department patients with chronic obstructive pulmonary disease exacerbationRespiratory impairment in older persons: when less means more.A randomised trial of lung sealant versus medical therapy for advanced emphysema.Use of lambda-mu-sigma-derived Z score for evaluating respiratory impairment in middle-aged personsThe SAFE (SGRQ score, air-flow limitation and exercise tolerance) Index: a new composite score for the stratification of severity in chronic obstructive pulmonary disease.Defining chronic obstructive pulmonary disease in older personsEthnic differences in respiratory impairment.Asthma-COPD overlap syndrome in the US: a prospective population-based analysis of patient-reported outcomes and health care utilization.Beyond FEV₁ in COPD: a review of patient-reported outcomes and their measurement.A Multicenter RCT of Zephyr® Endobronchial Valve Treatment in Heterogeneous Emphysema (TRANSFORM).Biologic lung volume reduction in advanced upper lobe emphysema: phase 2 results.Assessment of a novel lung sealant for performing endoscopic volume reduction therapy in patients with advanced emphysema.
P2860
Q24597329-0197827F-4326-413D-BE66-0E9DF209A0AFQ33727936-F9FC6EF4-001A-45C3-B428-199CB85A784FQ33752336-FE86997F-B678-41D8-AFCE-0C6A5A86221EQ33931328-14191371-A100-4A73-9C79-DB6F10D82601Q34621079-EE57AA62-7A5B-4820-B0E9-0EC842079C3DQ34761233-548B4B2F-6D9B-4608-9B62-3779CE4DDA58Q35173527-FB40CC08-F8EF-4166-8E80-DE89225E58C7Q35201858-879D35F3-8068-4AFE-8C29-C60FD295B675Q35404167-E470A329-B5C2-43FE-BDDD-7268121E9B3BQ35542883-E2490A3B-920E-47E4-BFBA-45117B0292D5Q35581457-FF31ED79-9492-4E24-AC02-04AF082D78F2Q35616872-0B93B307-5C61-4744-B421-29E1B02C2F53Q36130247-11787143-E1CE-4A3E-ADEA-7C5F3781C4C3Q36469780-AD2C5958-0C7F-42F1-839F-F3BCCF10CBA0Q36487529-B4553B82-7BF7-4906-8095-BB046E957BBEQ36782691-0BAC7179-42B9-4CAD-AE46-BEF19AE30564Q36913883-006A4451-7CBE-4FF3-BA41-C1330FB18D4FQ37008744-979C7395-A88E-49B6-BF77-A61939C0BCCAQ37336211-83CE476B-49A1-408E-8A74-58D1ACA2A05EQ37586278-F0045318-F8AB-4831-BB93-BFEAEE3C3025Q37638731-887D8FDB-EC6A-417D-BB50-CDFB4FA9FA5EQ38055149-B4E99C4F-1E09-4719-AAC2-04BE3F4453B6Q40060849-A631E803-815B-4426-8590-85CD2C914307Q40398456-5FED69D1-5BD2-45E7-804C-9AA3AF5479A7Q51572254-064A876C-6F93-4073-AC7A-5BA6D557DB84
P2860
Chronic obstructive pulmonary disease outcome measurements: what's important? What's useful?
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Chronic obstructive pulmonary ...... at's important? What's useful?
@ast
Chronic obstructive pulmonary ...... at's important? What's useful?
@en
type
label
Chronic obstructive pulmonary ...... at's important? What's useful?
@ast
Chronic obstructive pulmonary ...... at's important? What's useful?
@en
prefLabel
Chronic obstructive pulmonary ...... at's important? What's useful?
@ast
Chronic obstructive pulmonary ...... at's important? What's useful?
@en
P1476
Chronic obstructive pulmonary ...... at's important? What's useful?
@en
P2093
Nicholas J Gross
P304
267-71; discussion 290-1
P356
10.1513/PATS.200504-036SR
P577
2005-01-01T00:00:00Z